Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Bajaj, Jasmohan S ^a   Ahluwalia, Vishwadeep ^a   Steinberg, Joel L ^a   Hobgood, Sarah ^a   Boling, Peter A ^a   Godschalk, Michael ^a   Habib, Saima ^a   White, Melanie B ^a   Fagan, Andrew ^a   Gavis, Edith A ^a   Ganapathy, Dinesh ^a   Hylemon, Phillip B ^a   Stewart, Karen E ^a   Keradman, Raffi ^b   Liu, Eric J ^b   Wang, Jessica ^b   Gillevet, Patrick M ^b   Sikaroodi, Masoumeh ^b   Moeller, F Gerard ^a   Wade, James B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE;

AGED; BRAIN; BRAIN MAPPING; CINGULATE GYRUS; COGNITION; DEMOGRAPHY; FEMALE; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; MALE; METABOLISM; METABOLOME; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; QUALITY OF LIFE;

AGED; BRAIN; BRAIN MAPPING; COGNITION; CYTOKINES; DEMOGRAPHY; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GYRUS CINGULI; HUMANS; INFLAMMATION MEDIATORS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; METABOLOME; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE;

EID: 85002895777     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38481     Document Type: Article

References (43)

1. http://www.cdc.gov/aging/aginginfo/alzheimers.htm.Author: Centers for Disease Control and Prevention, Atlanta, GA, Title: Alzheimer's Disease, Year published 2015, last accessed 01/08/2016.
2. Rakoski, M. O. et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology 55, 184-191, doi: 10.1002/hep.24616 (2012).
3. Vilstrup, H. et al. Hepatic encephalopathy in chronic liver disease: Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60, 715-735, doi: 10.1002/hep.27210 (2014).
4. Mooney, S. et al. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with endstage liver disease awaiting liver transplant. Arch Clin Neuropsychol 22, 175-186, doi: 10.1016/j.acn.2006.12.005 (2007).
5. Wang, C. W. et al. Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study. Liver Transpl 21, 1465-1470, doi: 10.1002/lt.24334 (2015).
6. Campagna, F. et al. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20, 977-986, doi: 10.1002/lt.23909 (2014).
7. Caracciolo, B., Xu, W., Collins, S., Fratiglioni, L. Cognitive decline, dietary factors and gut-brain interactions. Mech Ageing Dev 136-137, 59-69, doi: 10.1016/j.mad.2013.11.011 (2014).
8. Quigley, E. M. Commentary: synbiotics and gut microbiota in older people-a microbial guide to healthy ageing. Aliment Pharmacol Ther 38, 1141-1142, doi: 10.1111/apt.12495 (2013).
9. Ahluwalia, V. et al. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis. Sci Rep 6, 26800, doi: 10.1038/srep26800 (2016).
10. Bajaj, J. S., Betrapally, N. S., Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature, doi: 10.1038/nature14851 (2015).
11. Bajaj, J. S. et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 302, G168-175 (2012).
12. Cevenini, E., Monti, D., Franceschi, C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care 16, 14-20, doi: 10.1097/MCO.0b013e32835ada13 (2013).
13. Heister, D. et al. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 77, 1619-1628, doi: 10.1212/WNL.0b013e3182343314 (2011).
14. Landau, S. M. et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75, 230-238, doi: 10.1212/WNL.0b013e3181e8e8b8 (2010).
15. McPhail, M. J. et al. Modulation of neural activation following treatment of hepatic encephalopathy. Neurology 80, 1041-1047, doi: 10.1212/WNL.0b013e31828726e1 (2013).
16. Sarma, M. K. et al. Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Metab Brain Dis 26, 173-184, doi: 10.1007/s11011-011-9250-1 (2011).
17. Wang, H. et al. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis. J Alzheimers Dis 46, 1049-1070, doi: 10.3233/JAD-143225 (2015).
18. Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184, doi: 10.1038/nature11319 (2012).
19. Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 60, 940-947, doi: 10.1016/j.jhep.2013.12.019 (2014).
20. Miquel, S. et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 16, 255-261, doi: 10.1016/j. mib.2013.06.003 (2013).
21. Eeckhaut, V. et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745-1752, doi: 10.1136/gutjnl-2012-303611 (2013).
22. Geirnaert, A. et al. Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30, 70-74, doi: 10.1016/j.anaerobe.2014.08.010 (2014).
23. Biagi, E. et al. Through ageing., beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5, e10667, doi: 10.1371/journal.pone.0010667 (2010).
24. Johansson, J. U. et al. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. J Clin Invest 125, 350-364, doi: 10.1172/JCI77487 (2015).
25. Shawcross, D. L., Davies, N. A., Williams, R., Jalan, R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40, 247-254 (2004).
26. Capobianchi, M. R., Uleri, E., Caglioti, C., Dolei, A. Type I IFN family members: similarity, differences and interaction. Cytokine Growth Factor Rev 26, 103-111, doi: 10.1016/j.cytogfr.2014.10.011 (2015).
27. Shawcross, D. L. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy Expert Rev Gastroenterol Hepatol 9, 539-542, doi: 10.1586/17474124.2015.1035257 (2015).
28. Macfarlane, S., Cleary, S., Bahrami, B., Reynolds, N., Macfarlane, G. T. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebocontrolled crossover study. Aliment Pharmacol Ther 38, 804-816, doi: 10.1111/apt.12453 (2013).
29. Bajaj, J. S. et al. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study. Liver Transpl 18, 1179-1187, doi: 10.1002/lt.23484 (2012).
30. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., Erbaugh, J. An inventory for measuring depression. Arch Gen Psychiatry 4, 561-571 (1961).
31. Allampati, S. et al. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. Am J Gastroenterol 111, 78-86, doi: 10.1038/ajg.2015.377 (2016).
32. Hogervorst, E. et al. The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord 13, 13-20 (2002).
33. Randolph, C., Tierney, M. C., Mohr, E., Chase, T. N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20, 310-319, doi: 10.1076/jcen.20.3.310.823 (1998).
34. Wechsler, D. Wechsler Individual Achievement Test (Psychological Corporation, 2002).
35. Bajaj, J. S. et al. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther 34, 1123-1132, doi: 10.1111/j.1365-2036.2011.04842.x (2011).
36. Gillevet, P., Sikaroodi, M., Keshavarzian, A., Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7, 1065-1075 (2010).
37. Bajaj, J. S., Betrapally, N. S., Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature 525, E1-2, doi: 10.1038/nature14851 (2015).
38. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60, doi: 10.1186/gb-2011-12-6-r60 (2011).
39. Garavan, H., Ross, T. J., Stein, E. A. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci USA 96, 8301-8306 (1999).
40. Woolrich, M. W., Ripley, B. D., Brady, M., Smith, S. M. Temporal autocorrelation in univariate linear modeling of FMRI data. NeuroImage 14, 1370-1386 (2001).
41. Provencher, S. W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30, 672-679 (1993).
42. Smith, S. M. et al. Accurate, robust., automated longitudinal and cross-sectional brain change analysis. Neuroimage 17, 479-489 (2002).
43. Patenaude, B., Smith, S. M., Kennedy, D. N., Jenkinson, M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56, 907-922, doi: 10.1016/j.neuroimage.2011.02.046 (2011).